CME Group competitors and alternatives include Nasdaq, S&P Global, etc.…
Income Statement
Assets & Liabilities | Cash Flow
Profitability
Ratios
Valuation
| 2022 | 4015600000.00 |
|---|---|
| 2023 | 4665600000.00 |
| 2024 | 5039100000.00 |
| 2025 | 5720300000.00 |
| 2022 | 1853000000.00 |
|---|---|
| 2023 | 1996000000.00 |
| 2024 | 2460000000.00 |
| 2025 | 3127000000.00 |
| 2022 | 6019000000.00 |
|---|---|
| 2023 | 5148000000.00 |
| 2024 | 6778000000.00 |
| 2025 | 7693000000.00 |
| 2022 | 3455000000.00 |
|---|---|
| 2023 | 4917000000.00 |
| 2024 | 6075000000.00 |
| 2025 | 6643000000.00 |
| 2022 | 2966300000.00 |
|---|---|
| 2023 | 3377400000.00 |
| 2024 | 3596500000.00 |
| 2025 | 4277100000.00 |
| 2022 | 1554000000.00 |
|---|---|
| 2023 | 1538000000.00 |
| 2024 | 1732000000.00 |
| 2025 | 1989000000.00 |
| 2022 | 2514000000.00 |
|---|---|
| 2023 | 3567000000.00 |
| 2024 | 5565000000.00 |
| 2025 | 5456000000.00 |
| 2022 | 3072000000.00 |
|---|---|
| 2023 | 3053000000.00 |
| 2024 | 4203000000.00 |
| 2025 | 4289000000.00 |